Related Experiment Videos
[Nephropathies and arterial hypertension]
1Service de Néphrologie et d'Hypertension artérielle, Centre Hospitalier, Vanes.
Presse Medicale (Paris, France : 1983)
|May 24, 1997
Summary
Hypertension is highly prevalent in patients with end-stage renal disease and kidney transplant recipients. Controlling high blood pressure is crucial for improving the prognosis of renal failure.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Context:
- Hypertension affects 85% of patients with end-stage renal disease (ESRD) and is also prevalent in renal transplant recipients.
- Primary renal disease can lead to hypertension via volume overload (reduced sodium excretion) or renin-dependent mechanisms.
- Factors like hyperfiltration, elevated glomerular capillary pressure, and angiotensin converting enzyme gene polymorphism contribute to chronic kidney disease progression.
Purpose:
- To summarize the high prevalence and potential mechanisms of hypertension in renal disease.
- To highlight the prognostic significance of hypertension in kidney disease.
- To underscore the benefits of hypertension control and specific drug classes in managing renal failure.
Summary:
- Hypertension is a critical issue in ESRD and post-transplant patients, with diverse underlying mechanisms including volume and renin dependency.
- Elevated blood pressure is a predictor of poor outcomes in renal disease.
- Interventions targeting hypertension, particularly converting enzyme inhibitors, demonstrate efficacy in slowing renal failure progression, even in diabetic patients.
Impact:
- Emphasizes the strong link between hypertension and renal disease, affecting 85% of ESRD patients.
- Underscores that managing hypertension improves the course of renal failure.
- Suggests specific therapeutic strategies, like converting enzyme inhibitors, for better patient outcomes.